Cancer Drug May Help Patients With Heart-lung Disease
Tuesday, May 20, 2008 - 21:28
in Health & Medicine
A drug developed to fight cancer is showing early promise as a treatment for pulmonary hypertension. In the first human trial of sorafenib as a treatment for pulmonary hypertension, 8 out of the first 9 patients increased their ability to exercise. Six out of 9 had improved right ventricular ejection fraction. Four had a significant decrease in pulmonary artery pressures.
Read the whole article on Science Daily
More from Science Daily
Related
- Cancer drug may help patients with heart-lung diseaseTue, 20 May 2008, 22:30:12 EDT
- UC San Diego researchers reverse pulmonary arterial hypertension in mouse modelsSun, 25 Oct 2009, 13:51:21 EDT
- Endothelin drugs benefit those with pulmonary hypertensionThu, 10 Sep 2009, 13:58:44 EDT
- NHLBI stops study of pulmonary hypertension treatment in sickle cell patientsTue, 28 Jul 2009, 16:42:46 EDT
- Medication may improve portal hypertensionWed, 1 Apr 2009, 11:36:27 EDT